Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1995 Jul;85(3):394–399.

Expression of functional insulin-like growth factor-1 receptor on lymphoid cell subsets of rats.

X Xu 1, C Mardell 1, C J Xian 1, H Zola 1, L C Read 1
PMCID: PMC1383912  PMID: 7558127

Abstract

It has become evident that insulin-like growth factor-1 (IGF-1) acts as a growth factor for immune cells, yet the precise regulatory role of IGF-1 in the immune system is unknown. The aim of this study was to examine the distribution of IGF-1 receptors on rat lymphoid cells. A flow cytometric method was used, with a biotinylated and functionally active IGF-1 analogue, namely des(1-3)IGF-1, which binds well to IGF-1 receptor but poorly to IGF binding proteins, followed by phycoerythrin-conjugated streptavidin (PE-SA) staining. Our results showed that IGF-1 receptors were readily detectable on a wide variety of the immune cells, including T cells, B cells and monocytes, but the binding capacity for IGF-1 was monocytes > B cells > T cells, as determined by titration experiments. Furthermore, the level of expression on resting CD4+ T lymphocytes was greater than on CD8+ cells, and the concentration of biotin-des(1-3)IGF-1 required to demonstrate the binding to IGF-1 receptor on CD8+ cells (68 nmol/l) was 200-fold higher than for CD4+ cells (0.34 nmol/l), indicating that most of the IGF-1 receptor on CD8+ cells represented lower affinity sites. The level of IGF-1 receptor expression was increased several-fold after concanavalin A stimulation on both CD4+ and CD8+ T-cell subsets. Kinetic analysis of the expression of IGF-1 receptor and its association with interleukin-2 receptors (IL-2R) following activation showed a similar pattern, with no significant differences in the ratio of IGF-1 receptor: IL-2R per cell during the 3 days of cell culture. Our studies suggest that biological activities of IGF-1 include direct stimulation of immune cells, and that expression of IGF-1 receptor may have a role in regulation of T-cell function.

Full text

PDF
394

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballard F. J., Read L. C., Francis G. L., Bagley C. J., Wallace J. C. Binding properties and biological potencies of insulin-like growth factors in L6 myoblasts. Biochem J. 1986 Jan 1;233(1):223–230. doi: 10.1042/bj2330223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Binz K., Joller P., Froesch P., Binz H., Zapf J., Froesch E. R. Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor I. Proc Natl Acad Sci U S A. 1990 May;87(10):3690–3694. doi: 10.1073/pnas.87.10.3690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cantrell D. A., Smith K. A. The interleukin-2 T-cell system: a new cell growth model. Science. 1984 Jun 22;224(4655):1312–1316. doi: 10.1126/science.6427923. [DOI] [PubMed] [Google Scholar]
  4. Clark R., Strasser J., McCabe S., Robbins K., Jardieu P. Insulin-like growth factor-1 stimulation of lymphopoiesis. J Clin Invest. 1993 Aug;92(2):540–548. doi: 10.1172/JCI116621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Czech M. P. Signal transmission by the insulin-like growth factors. Cell. 1989 Oct 20;59(2):235–238. doi: 10.1016/0092-8674(89)90281-x. [DOI] [PubMed] [Google Scholar]
  6. Forbes B., Szabo L., Baxter R. C., Ballard F. J., Wallace J. C. Classification of the insulin-like growth factor binding proteins into three distinct categories according to their binding specificities. Biochem Biophys Res Commun. 1988 Nov 30;157(1):196–202. doi: 10.1016/s0006-291x(88)80032-9. [DOI] [PubMed] [Google Scholar]
  7. Hsu D., Olefsky J. M. Effect of a major histocompatibility complex class I peptide on insulin-like growth factor-I receptor internalization and biological signaling. Endocrinology. 1993 Sep;133(3):1247–1251. doi: 10.1210/endo.133.3.8365366. [DOI] [PubMed] [Google Scholar]
  8. Jonas H. A., Cox A. J. Insulin receptor sub-types in a human lymphoid-derived cell line (IM-9): differential regulation by insulin, dexamethasone and monensin. J Recept Res. 1991;11(5):813–829. doi: 10.3109/10799899109064681. [DOI] [PubMed] [Google Scholar]
  9. Kozak R. W., Haskell J. F., Greenstein L. A., Rechler M. M., Waldmann T. A., Nissley S. P. Type I and II insulin-like growth factor receptors on human phytohemagglutinin-activated T lymphocytes. Cell Immunol. 1987 Oct 15;109(2):318–331. doi: 10.1016/0008-8749(87)90315-7. [DOI] [PubMed] [Google Scholar]
  10. Nyman T., Pekonen F. The expression of insulin-like growth factors and their binding proteins in normal human lymphocytes. Acta Endocrinol (Copenh) 1993 Feb;128(2):168–172. doi: 10.1530/acta.0.1280168. [DOI] [PubMed] [Google Scholar]
  11. Read L. C., Ballard F. J., Francis G. L., Baxter R. C., Bagley C. J., Wallace J. C. Comparative binding of bovine, human and rat insulin-like growth factors to membrane receptors and to antibodies against human insulin-like growth factor-1. Biochem J. 1986 Jan 1;233(1):215–221. doi: 10.1042/bj2330215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Reiss K., Porcu P., Sell C., Pietrzkowski Z., Baserga R. The insulin-like growth factor 1 receptor is required for the proliferation of hemopoietic cells. Oncogene. 1992 Nov;7(11):2243–2248. [PubMed] [Google Scholar]
  13. Roldan A., Charreau E., Schillaci R., Eugui E. M., Allison A. C. Insulin-like growth factor-1 increases the mitogenic response of human peripheral blood lymphocytes to phytohemagglutinin. Immunol Lett. 1989 Jan 15;20(1):5–8. doi: 10.1016/0165-2478(89)90060-6. [DOI] [PubMed] [Google Scholar]
  14. Rutanen E. M., Pekonen F. Insulin-like growth factors and their binding proteins. Acta Endocrinol (Copenh) 1990 Jul;123(1):7–13. doi: 10.1530/acta.0.1230007. [DOI] [PubMed] [Google Scholar]
  15. Stuart C. A., Meehan R. T., Neale L. S., Cintron N. M., Furlanetto R. W. Insulin-like growth factor-I binds selectively to human peripheral blood monocytes and B-lymphocytes. J Clin Endocrinol Metab. 1991 May;72(5):1117–1122. doi: 10.1210/jcem-72-5-1117. [DOI] [PubMed] [Google Scholar]
  16. Taga T., Kawanishi Y., Hardy R. R., Hirano T., Kishimoto T. Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression. J Exp Med. 1987 Oct 1;166(4):967–981. doi: 10.1084/jem.166.4.967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Taniguchi T., Minami Y. The IL-2/IL-2 receptor system: a current overview. Cell. 1993 Apr 9;73(1):5–8. doi: 10.1016/0092-8674(93)90152-g. [DOI] [PubMed] [Google Scholar]
  18. Tapson V. F., Boni-Schnetzler M., Pilch P. F., Center D. M., Berman J. S. Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro. J Clin Invest. 1988 Sep;82(3):950–957. doi: 10.1172/JCI113703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Weiss A., Imboden J. B. Cell surface molecules and early events involved in human T lymphocyte activation. Adv Immunol. 1987;41:1–38. doi: 10.1016/s0065-2776(08)60029-2. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES